Fish Oil and Inflammation in Overweight Subjects
NCT00885053 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2010-01-26
Summary
The aim of this study is to investigate the effects of acute and short-term intervention with fish oil on inflammatory markers in overweight subjects.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
fish oil
Capsules. Approximately 1000 mg n-3 PUFA daily. One day + 6 weeks
- DIETARY_SUPPLEMENT
-
olive oil
Capsules. Approximately 1 g olive oil daily. One day + 6 weeks
Sponsors & Collaborators
-
Aalborg University Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 30 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-04-30
- Primary Completion
- 2009-12-31
- Completion
- 2009-12-31
Countries
- Denmark
Study Locations
More Related Trials
-
Effects of Omega-3 PUFA on Lipids, Inflammatory Factors and Body Composition in Patients with Hyperlipidemia
NCT05015348 ·Status: RECRUITING ·Phase: NA
-
Investigating the Effect of 4-week Omega-3 Polyunsaturated Fatty Acid Supplementation on Inflammation
NCT03210805 ·Status: UNKNOWN ·Phase: NA
-
Effects of a Prescription Omega-3 Fatty Acid Concentrate on Induced Inflammation
NCT01813110 ·Status: COMPLETED ·Phase: NA
-
Effects of DHA on Pro-resolving Anti-inflammatory Mediators in Obese Patients Undergoing Weight-loss Treatment
NCT01865448 ·Status: COMPLETED ·Phase: NA
-
Effect of Combined Fatty Acid Supplementation and Eccentric Exercise Training on Exercise Performance
NCT03259412 ·Status: COMPLETED ·Phase: NA
-
Effect of HCCD Supplemented With Omega-3 Fatty-Acids on Inflammation in Healthy, Overweight Subjects
NCT00504478 ·Status: UNKNOWN ·Phase: NA
-
Effect of Oleic Acid on Inflammation Markers and Blood Lipid Metabolites: A Randomised, Double-Blind, Crossover Study
NCT00715312 ·Status: COMPLETED ·Phase: NA
-
Effects of Cetoleic Acid on Atherosclerosis (Ketolinsyre's Effekt på Aterosklerose)
NCT06172335 ·Status: RECRUITING ·Phase: NA
-
The Effects of Omega-3 Fatty Acids on Metabolic Syndrome
NCT00350194 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
The Effect of n-3 Polyunsaturated Fatty Acids in Patients With Psoriatic Arthritis
NCT01818804 ·Status: COMPLETED ·Phase: NA
-
Transcriptomics of Mononuclear Cells and Inflammatory Status of Obese Patients Treated With Omega-3 Fatty Acids
NCT05219890 ·Status: WITHDRAWN ·Phase: NA
-
Effect of 12 wk of Omega-3 FA Supplementation on Metabolic and Physical Health Parameters in Older Adults
NCT01734538 ·Status: UNKNOWN ·Phase: NA
-
Intake of Omega 3 in Morbidly Obese Patients
NCT02113696 ·Status: COMPLETED ·Phase: NA
-
Effect of a Mediterranean Diet and Omega-3 Fatty Acids on Oxidative Stress and Endothelial Progenitor Cells (EPC's)
NCT00166088 ·Status: COMPLETED ·Phase: PHASE2
-
The Impact of Fish-oil Fatty Acids on Postprandial Vascular Reactivity
NCT01692431 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Effects of a Marine Lipid Oil Concentrate Formulation on Inflammation
NCT04269876 ·Status: TERMINATED ·Phase: NA
-
Effect of Omega 3 Fatty Acids on Vascular Function
NCT01888211 ·Status: COMPLETED ·Phase: NA
-
n-3 Polyunsaturated Fatty Acids in Obesity
NCT00760760 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of a PUFA-rich Diet on Acute Metabolic and Inflammatory High-Fat Meal Responses
NCT02246933 ·Status: COMPLETED ·Phase: NA
-
Dietary Essential Fatty Acid Regulation of Omega-3 HUFA Metabolism; Satiety and Body Composition
NCT01251887 ·Status: COMPLETED ·Phase: NA
-
Dose Response Effects of Marine Omega-3 Fatty Acids on Inflammation
NCT01078909 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Omega-3 Fatty Acid on Endothelial Function
NCT01813006 ·Status: COMPLETED ·Phase: PHASE3
-
Omega-3 Fatty Acids and Health Effects
NCT01034423 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Supplementation and Resistance Training
NCT02617511 ·Status: COMPLETED ·Phase: NA
-
Effects of Omega-3 Docosapentaenoic Acid on Lipids and Other Risk Factors for Cardiovascular Disease
NCT04088240 ·Status: TERMINATED ·Phase: NA